Actively Recruiting
Cardiac Amyloidosis Registry of University Hospital Leipzig
Led by University of Leipzig · Updated on 2023-11-13
500
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a clinical registry of patients with cardiac amyloidosis being treated at University Hospital Leipzig. The aim of the registry is to collect detailed information about clinical events, symptoms, imaging, biomarkers, comorbidities, and treatment from routine patient management which would not be provided by randomized clinical trails.
CONDITIONS
Official Title
Cardiac Amyloidosis Registry of University Hospital Leipzig
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed cardiac amyloidosis according to current standards
You will not qualify if you...
- Refusal to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Leipzig
Leipzig, Saxony, Germany, 04103
Actively Recruiting
Research Team
D
Daniel Lavall, MD
CONTACT
R
Romy Gessner, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here